Literature DB >> 12423870

The management of preterm labor.

Robert L Goldenberg1.   

Abstract

Preterm birth is the leading cause of neonatal mortality and a substantial portion of all birth-related short- and long-term morbidity. Spontaneous preterm labor is responsible for more than half of preterm births. Its management is the topic of this review. Although there are many maternal characteristics associated with preterm birth, the etiology in most cases is not clear, although, for the earliest cases, the role of intrauterine infection is assuming greater importance. Most efforts to prevent preterm labor have not proven to be effective, and equally frustrating, most efforts at arresting preterm labor once started have failed. The most important components of management, therefore, are aimed at preventing neonatal complications through the use of corticosteroids and antibiotics to prevent group B streptococcal neonatal sepsis, and avoiding traumatic deliveries. Delivery in a medical center with an experienced resuscitation team and the availability of a newborn intensive care unit will ensure the best possible neonatal outcomes. Obstetric practices for which there is little evidence of effectiveness in preventing or treating preterm labor include the following: bed rest, hydration, sedation, home uterine activity monitoring, oral terbutaline after successful intravenous tocolysis, and tocolysis without the concomitant use of corticosteroids.

Entities:  

Mesh:

Year:  2002        PMID: 12423870     DOI: 10.1016/s0029-7844(02)02212-3

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  51 in total

1.  Evaluation of Granada agar plate for detection of Streptococcus agalactiae in urine specimens from pregnant women.

Authors:  Javier Tamayo; José-Luis Gómez-Garcés; Juan-Ignacio Alós
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

2.  Practices for predicting and preventing preterm birth in Ireland: a national survey.

Authors:  V Smith; D Devane; S Higgins
Journal:  Ir J Med Sci       Date:  2010-10-17       Impact factor: 1.568

3.  Humanized mice, a new model to study the influence of drug treatment on neonatal sepsis.

Authors:  Wolfgang Ernst; Nicole Zimara; Frank Hanses; Daniela N Männel; Birgit Seelbach-Göbel; Anja K Wege
Journal:  Infect Immun       Date:  2013-02-25       Impact factor: 3.441

4.  Ultrasonic attenuation estimation of the pregnant cervix: a preliminary report.

Authors:  B L McFarlin; T A Bigelow; Y Laybed; W D O'Brien; M L Oelze; J S Abramowicz
Journal:  Ultrasound Obstet Gynecol       Date:  2010-08       Impact factor: 7.299

Review 5.  Psychosocial stress in pregnancy and preterm birth: associations and mechanisms.

Authors:  Gabriel D Shapiro; William D Fraser; Martin G Frasch; Jean R Séguin
Journal:  J Perinat Med       Date:  2013-11       Impact factor: 1.901

Review 6.  The contribution of genetic and environmental factors to the duration of pregnancy.

Authors:  Timothy P York; Lindon J Eaves; Michael C Neale; Jerome F Strauss
Journal:  Am J Obstet Gynecol       Date:  2013-10-02       Impact factor: 8.661

7.  Prepregnancy depressive symptoms and preterm birth in the Black Women's Health Study.

Authors:  Ghasi S Phillips; Lauren A Wise; Janet W Rich-Edwards; Meir J Stampfer; Lynn Rosenberg
Journal:  Ann Epidemiol       Date:  2010-01       Impact factor: 3.797

8.  Prospective randomised controlled trial of an infection screening programme to reduce the rate of preterm delivery.

Authors:  Herbert Kiss; Ljubomir Petricevic; Peter Husslein
Journal:  BMJ       Date:  2004-08-04

9.  Uterine contractile effects of the aqueous and ethanol leaf extracts of Newbouldia Laevis (Bignoniaceae) in vitro.

Authors:  E Bafor; U Sanni
Journal:  Indian J Pharm Sci       Date:  2009-03       Impact factor: 0.975

Review 10.  Prostanoid receptor antagonists: development strategies and therapeutic applications.

Authors:  R L Jones; M A Giembycz; D F Woodward
Journal:  Br J Pharmacol       Date:  2009-07-15       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.